Oncotron: an effective antitumor drug from Germany
In the modern world, there are many diseases that require serious intervention and comprehensive treatment. Cancer occupies a special place among these problems. They require innovative and effective control methods. One of these methods is the use of antitumor agents that can inhibit the growth and development of malignant tumors. One of these drugs is Oncotron.
Oncotron is manufactured in Germany, at the pharmaceutical company Baxter Oncology GmbH. This drug belongs to the group of synthetic antitumor drugs of various categories. Its international name is Mitoxantrone, and it is also known by synonyms such as Mitoxantrone AVD, Mitoxantrone AVD 10, Mitoxantrone AVD 25, Mitoxantrone-LENS and Novantrone.
Oncotron is available in the form of an injection solution containing 2 mg/ml of the active substance - Mitoxantrone. This drug is effective in the treatment of various types of cancer, including metastatic breast cancer, liver, ovarian, prostate cancer, non-Hodgkin's lymphoma, and acute myeloid tumors.